OPT Congress 참가를 환영합니다.
올리고뉴클레오티드·mRNA 의약
2025년 플레너리 연사
Anastasia Khvorova, PhD
Professor, RNA Therapeutic Institute, University of Massachusetts Medical School
Eric Swayze, PhD
Executive Vice President, Research, Ionis Pharmaceuticals
Edward Kaye, MD
CEO and Director, Stoke Therapeutics
Rubina Parmar, PhD
Vice President, Chemistry & Delivery Sciences, Intellia Therapeutics
이그제큐티브 자문위원회
Mano Manoharan, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals
Dmitry Samarsky, PhD
Former CTO, Sirnaomics
Chandra Vargeese, PhD
CTO & Head, Platform Discovery Sciences, Wave Life Sciences
Arthur Levin, PhD
Executive Vice President, Research and Development, Avidity Biosciences
Lubo Nechev, PhD
Vice President Process and Analytical Sciences, Alnylam Pharmaceuticals
Ekkehard Leberer, PhD
Senior Life Sciences Consultant, ELBIOCON
OPT Congress Boston의 장면
